102 related articles for article (PubMed ID: 20524053)
1. Male infertility and prostate cancer risk: a nested case-control study.
Ruhayel Y; Giwercman A; Ulmert D; Rylander L; Bjartell A; Manjer J; Berglund G; Giwercman YL
Cancer Causes Control; 2010 Oct; 21(10):1635-43. PubMed ID: 20524053
[TBL] [Abstract][Full Text] [Related]
2. Fatty acids and risk of prostate cancer in a nested case-control study in male smokers.
Männistö S; Pietinen P; Virtanen MJ; Salminen I; Albanes D; Giovannucci E; Virtamo J
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1422-8. PubMed ID: 14693732
[TBL] [Abstract][Full Text] [Related]
3. Vasectomy and prostate cancer risk in China.
Hsing AW; Wang RT; Gu FL; Lee M; Wang T; Leng TJ; Spitz M; Blot WJ
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):285-8. PubMed ID: 8061575
[TBL] [Abstract][Full Text] [Related]
4. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
[TBL] [Abstract][Full Text] [Related]
5. Duration of gestation and prostate cancer risk in offspring.
Ekbom A; Wuu J; Adami HO; Lu CM; Lagiou P; Trichopoulos D; Hsieh C
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):221-3. PubMed ID: 10698486
[TBL] [Abstract][Full Text] [Related]
6. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J; Högstedt B
Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
[TBL] [Abstract][Full Text] [Related]
7. Total food consumption and body mass index in relation to prostate cancer risk: a case-control study in Sweden with prospectively collected exposure data.
Grönberg H; Damber L; Damber JE
J Urol; 1996 Mar; 155(3):969-74. PubMed ID: 8583620
[TBL] [Abstract][Full Text] [Related]
8. Androgens in serum and the risk of prostate cancer: a nested case-control study from the Janus serum bank in Norway.
Vatten LJ; Ursin G; Ross RK; Stanczyk FZ; Lobo RA; Harvei S; Jellum E
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):967-9. PubMed ID: 9367072
[TBL] [Abstract][Full Text] [Related]
9. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
[TBL] [Abstract][Full Text] [Related]
10. Lactase persistence, dietary intake of milk, and the risk for prostate cancer in Sweden and Finland.
Torniainen S; Hedelin M; Autio V; Rasinperä H; Bälter KA; Klint A; Bellocco R; Wiklund F; Stattin P; Ikonen T; Tammela TL; Schleutker J; Grönberg H; Järvelä I
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):956-61. PubMed ID: 17507622
[TBL] [Abstract][Full Text] [Related]
11. Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.
Woodson K; Tangrea JA; Pollak M; Copeland TD; Taylor PR; Virtamo J; Albanes D
Cancer Res; 2003 Jul; 63(14):3991-4. PubMed ID: 12873996
[TBL] [Abstract][Full Text] [Related]
12. Diabetes mellitus and the risk of prostate cancer in Italy.
Tavani A; Gallus S; Bertuzzi M; Dal Maso L; Zucchetto A; Negri E; Franceschi S; Ramazzotti V; Montella M; La Vecchia C
Eur Urol; 2005 Mar; 47(3):313-7; discussion 317. PubMed ID: 15716192
[TBL] [Abstract][Full Text] [Related]
13. A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer.
Ewart-Toland A; Chan JM; Yuan J; Balmain A; Ma J
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):759-64. PubMed ID: 15159307
[TBL] [Abstract][Full Text] [Related]
14. Obesity, adipokines, and prostate cancer in a prospective population-based study.
Baillargeon J; Platz EA; Rose DP; Pollock BH; Ankerst DP; Haffner S; Higgins B; Lokshin A; Troyer D; Hernandez J; Lynch S; Leach RJ; Thompson IM
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1331-5. PubMed ID: 16835332
[TBL] [Abstract][Full Text] [Related]
15. Lifestyle factors and prostate cancer risk: a case-control study in Sweden.
Andersson SO; Baron J; Bergström R; Lindgren C; Wolk A; Adami HO
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):509-13. PubMed ID: 8827354
[TBL] [Abstract][Full Text] [Related]
16. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
[TBL] [Abstract][Full Text] [Related]
17. Association between nonsteroidal anti-inflammatory drugs and prostate cancer occurrence.
Dasgupta K; Di Cesar D; Ghosn J; Rajan R; Mahmud S; Rahme E
Cancer J; 2006; 12(2):130-5. PubMed ID: 16630404
[TBL] [Abstract][Full Text] [Related]
18. Obesity and the risk of prostate cancer.
Porter MP; Stanford JL
Prostate; 2005 Mar; 62(4):316-21. PubMed ID: 15389806
[TBL] [Abstract][Full Text] [Related]
19. Vasectomy and prostate cancer.
Lesko SM; Louik C; Vezina R; Rosenberg L; Shapiro S
J Urol; 1999 Jun; 161(6):1848-52; discussion 1852-3. PubMed ID: 10332451
[TBL] [Abstract][Full Text] [Related]
20. Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer.
Sutcliffe S; Giovannucci E; Alderete JF; Chang TH; Gaydos CA; Zenilman JM; De Marzo AM; Willett WC; Platz EA
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):939-45. PubMed ID: 16702374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
